In fact, knowledge of the relative importance of hepatic versus extrahepatic components of insulin clearance and their relationship with the incretin system may be of help in the development of therapeutic agents for type 2 diabetes, especially in addressing possible defects in the balance between these mechanisms. The gene discussed is INS; the disease is type 2 diabetes mellitus.